Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Leflunomide is more likely to help treat alopecia areata than cause it.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Fat cells help recruit healing cells and build skin structure during wound healing.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

Regulatory T cells are essential for normal and improved wound healing in mice.

Understanding different species' regeneration can improve mammalian healing.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

COVID-19 may harm male fertility and damage the reproductive system.

Collagen peptides may help reduce skin aging by improving elasticity and hydration.

Researchers used CRISPR/Cas9 to create a goat with a gene that increased cashmere production by 74.5% without affecting quality.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Signaling pathways are key targets for developing effective drugs.

Hair pattern in androgenetic alopecia overlaps with scalp and bone demarcations, with distinct gene profiles affecting susceptibility.

γδ T cells adapt uniquely to different tissues in mice.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.